Home | Contact Us 

Online Catalog

View our online catalog.
For further information or for a quotation, call 1-510-475-0650 or email us at

How Can We Help You?
Click here to contact us!


Sepragen Corporation Announces Management Addition To Focus On Dairy Opportunities

Union City, CA, September 24, 1999 - Sepragen Corporation (OTC BB: SPGNU, SPGNA, SPGNW) announced the addition of Mr. Werner Kofod Nielsen as Director of Dairy Business Development. Sepragen has recently announced the commercialization of its patented Sepralac® Process at two of its current licensees, Anchor Products, Ltd., of New Zealand, and Carbery Food Ingredients, of Ireland.

Mr. Nielsen has a career spanning over 30 years in the dairy industry with senior positions including General Manager of DDS Filtration and Technical Director of Dairy and Food Division for giant food equipment supplier APV. He is presently also Chairman of Danish Food Industry Forum. Mr. Nielsen’s focus will be to establish the Sepralac® Process as the standard process of choice amongst leading dairy producers for making high value protein ingredients for the next generation infant formula, geriatric foods, sports nutrition and nutraceutical markets. About his joining Sepragen, Mr. Nielsen had the following to say, “Sepragen has unique and patented technology that can be used for the production of high value ingredients for the dairy industry. My career which has spanned over 30 years has been involved with upgrading whey from a waste product to a high value nutritional source with a variety of technologies, including membrane filtration. I am confident that the major dairy processors will embrace the Sepralac® technology as Anchor Products and Carbery have done and am excited about this opportunity.”

Sepragen Corporation develops and markets technology along with equipment and supplies for process chromatography applications. Sepragen has developed a number of patented applications that provide large market opportunities in the food and beverage industry, including debittering citrus juices, extracting isoflavone (plant estrogen) from soy, as well as extracting proteins from whey. The company holds over 14 issued patents relating to its core technology.

Return to News Archives main page

The statements in this release that relate to future events or performance, statements about growth, future regulatory clearances, levels of sales and market size and future manufacturing capacity and efficiencies are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to the development of markets for and commercial acceptance of the company's products and services, the availability of components, competitors' product introductions and other risks identified in the company's SEC filings. Actual results may differ from those described in these forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof.

Company | Products | News and Events | Contact Us | Terms and Conditions | Privacy Policy © 2020 Sepragen Corporation. All rights reserved. (510) 475-0650